MPO and Cachexia: In addition, when comparing cachectic patients with high versus low levels of LCN-2, the median MPO levels of cachectic patients in the high LCN-2 group were significantly higher than those of cachectic patients with low LCN-2 or those found in patients without cachexia (median 30.3 (22.1-37.9) ng/mL vs. 20.2 (15.0-29.2) ng/mL, p=0.011; vs. 16.3 (12.0-27.5) ng/mL, p=0.021, respectively) (Figure 4A).